Menthol cigarette restrictions could lead to healthier choices

Nationwide, fewer people smoke than did a decade ago, but the proportion who smoke menthol-flavored cigarettes is on the rise.

Want to make better pharma ads? Try using humor and more branding, Kantar analyst says

Pharma advertising hits the mark for news and relevance, but typically disappoints when it comes to being enjoyable. That’s according to Kantar analyst Polly Wyn

January 12, 2024

Psilocybin-Assisted Therapy Shows Promising Phase 1 Results In Anorexia Nervosa Trial

A phase 1 clinical trial was conducted to investigate the potential of a single dose of psilocybin combined with psychotherapy as a treatment for anorexia

July 26, 2023

Immunic Announces Publication of Data From Phase 1/1b Clinical Trial of IMU-856 in the Peer Reviewed Journal, The Lancet Gastroenterology & Hepatology – Biotech Investments

Issuer: Immunic AG / Key word(s): Scientific publication 13.11.2024 / 12:30 CET/CEST The issuer is solely responsible for the content of this announcement. Immunic Announces

November 14, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.